Susquehanna Fundamental Investments, LLC Cassava Sciences Inc Transaction History

Susquehanna Fundamental Investments, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$7.09 - $87.95 $120,841 - $1.5 Million	-17,044 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$6.79 - $12.25 $17,273 - $31,164	2,544 Added 17.54%	17,044 $116,000
Q2 2020 Aug 14, 2020	BUY	$2.04 - $9.64 $29,580 - $139,780	14,500 New	14,500 $45,000

189

13.5M

1.38M

2.26M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $1.08B
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.